Literature DB >> 23961712

Chronotype and breast cancer risk in a cohort of US nurses.

Cody Ramin1, Elizabeth E Devore, Jeffrey Pierre-Paul, Jeanne F Duffy, Susan E Hankinson, Eva S Schernhammer.   

Abstract

The aim of this study was to examine the relation between chronotype and breast cancer risk. We analyzed the association between chronotype (definite morning type, probable morning type, probable evening type, definite evening type, or neither morning nor evening type) and breast cancer risk among 72 517 women in the Nurses' Health Study II (NHS II). Chronotype was self-reported in 2009, and 1834 breast cancer cases were confirmed among participants between 1989 and 2007; a 2-yr lag period was imposed to account for possible circadian disruptions related to breast cancer diagnosis. Age- and multivariable-adjusted logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Participants who self-reported as neither morning nor evening type had a 27% increased risk of breast cancer (multivariable-adjusted OR = 1.27, 95% CI = 1.04-1.56), compared with definite morning types. None of the other chronotypes were significantly associated with breast cancer risk (multivariable-adjusted OR = 0.99, 95% CI = 0.87-1.12 for probable morning versus definite morning types; OR = 0.96, 95% CI = 0.84-1.09 for probable evening versus definite morning types; and OR = 1.15, 95% CI = 0.98-1.34 for definite evening versus definite morning types). Overall, chronotype was not associated with breast cancer risk in our study. A modestly increased risk among neither morning nor evening types may indicate circadian disruption as a potentially underlying mechanism; however, more studies are needed to confirm our results.

Entities:  

Mesh:

Year:  2013        PMID: 23961712      PMCID: PMC4007068          DOI: 10.3109/07420528.2013.809359

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  31 in total

Review 1.  Individual differences in tolerance to shift work--a systematic review.

Authors:  Ingvild B Saksvik; Bjørn Bjorvatn; Hilde Hetland; Gro M Sandal; Ståle Pallesen
Journal:  Sleep Med Rev       Date:  2010-09-20       Impact factor: 11.609

2.  Hypotheses for mechanisms linking shiftwork and cancer.

Authors:  L Fritschi; D C Glass; J S Heyworth; K Aronson; J Girschik; T Boyle; A Grundy; T C Erren
Journal:  Med Hypotheses       Date:  2011-07-01       Impact factor: 1.538

3.  A silent polymorphism in the PER1 gene associates with extreme diurnal preference in humans.

Authors:  Jayshan D Carpen; Malcolm von Schantz; Marcel Smits; Debra J Skene; Simon N Archer
Journal:  J Hum Genet       Date:  2006-10-19       Impact factor: 3.172

4.  Does the chronotype classification need to be updated? Preliminary findings.

Authors:  Bruno Jacson Martynhak; Fernando Mazzilli Louzada; Mário Pedrazzoli; John Fontenele Araujo
Journal:  Chronobiol Int       Date:  2010-07       Impact factor: 2.877

5.  Rotating nightshift work and the risk of endometriosis in premenopausal women.

Authors:  Eva S Schernhammer; Allison F Vitonis; Janet Rich-Edwards; Stacey A Missmer
Journal:  Am J Obstet Gynecol       Date:  2011-06-12       Impact factor: 8.661

6.  CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses.

Authors:  Aaron E Hoffman; Chun-Hui Yi; Tongzhang Zheng; Richard G Stevens; Derek Leaderer; Yawei Zhang; Theodore R Holford; Johnni Hansen; Jennifer Paulson; Yong Zhu
Journal:  Cancer Res       Date:  2010-02-02       Impact factor: 12.701

7.  Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.

Authors:  Yong Zhu; Richard G Stevens; Derek Leaderer; Aaron Hoffman; Theodore Holford; Yawei Zhang; Heather N Brown; Tongzhang Zheng
Journal:  Breast Cancer Res Treat       Date:  2007-04-24       Impact factor: 4.872

Review 8.  Melatonin, sleep disturbance and cancer risk.

Authors:  David E Blask
Journal:  Sleep Med Rev       Date:  2008-12-17       Impact factor: 11.609

9.  Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm.

Authors:  Xiaoming Yang; Patricia A Wood; Eun-Young Oh; Jovelyn Du-Quiton; Christine M Ansell; William J M Hrushesky
Journal:  Breast Cancer Res Treat       Date:  2008-07-24       Impact factor: 4.872

10.  Shift work in nurses: contribution of phenotypes and genotypes to adaptation.

Authors:  Karen L Gamble; Alison A Motsinger-Reif; Akiko Hida; Hugo M Borsetti; Stein V Servick; Christopher M Ciarleglio; Sam Robbins; Jennifer Hicks; Krista Carver; Nalo Hamilton; Nancy Wells; Marshall L Summar; Douglas G McMahon; Carl Hirschie Johnson
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

View more
  16 in total

1.  Night shift work at specific age ranges and chronic disease risk factors.

Authors:  Cody Ramin; Elizabeth E Devore; Weike Wang; Jeffrey Pierre-Paul; Lani R Wegrzyn; Eva S Schernhammer
Journal:  Occup Environ Med       Date:  2014-09-26       Impact factor: 4.402

2.  Sleep disruption, chronotype, shift work, and prostate cancer risk and mortality: a 30-year prospective cohort study of Finnish twins.

Authors:  Barbra A Dickerman; Sarah C Markt; Markku Koskenvuo; Christer Hublin; Eero Pukkala; Lorelei A Mucci; Jaakko Kaprio
Journal:  Cancer Causes Control       Date:  2016-10-12       Impact factor: 2.506

3.  Persistence of social jetlag and sleep disruption in healthy young adults.

Authors:  Daria M McMahon; James B Burch; Michael D Wirth; Shawn D Youngstedt; James W Hardin; Thomas G Hurley; Steven N Blair; Gregory A Hand; Robin P Shook; Clemens Drenowatz; Stephanie Burgess; James R Hebert
Journal:  Chronobiol Int       Date:  2017-12-12       Impact factor: 2.877

4.  Case-control study of breast cancer in India: Role of PERIOD3 clock gene length polymorphism and chronotype.

Authors:  Michael D Wirth; James B Burch; James R Hébert; Pradnya Kowtal; Aparna Mehrotra-Kapoor; Susan E Steck; Thomas G Hurley; Prakash C Gupta; Mangesh S Pednekar; Shawn D Youngstedt; Hongmei Zhang; Rajiv Sarin
Journal:  Cancer Invest       Date:  2014-06-06       Impact factor: 2.176

5.  Chronotype and postmenopausal breast cancer risk among women in the California Teachers Study.

Authors:  Susan Hurley; Debbie Goldberg; Julie Von Behren; Jessica Clague DeHart; Sophia Wang; Peggy Reynolds
Journal:  Chronobiol Int       Date:  2019-08-27       Impact factor: 2.877

6.  The role of chronotype, circadian misalignment, and tiredness in the substance use behaviors of gay and bisexual men.

Authors:  Brett M Millar; H Jonathon Rendina; Tyrel J Starks; Christian Grov; Jeffrey T Parsons
Journal:  Psychol Sex Orientat Gend Divers       Date:  2018-11-05

7.  Breast cancer risk and night shift work in a case-control study in a Spanish population.

Authors:  Kyriaki Papantoniou; Gemma Castaño-Vinyals; Ana Espinosa; Nuria Aragonés; Beatriz Pérez-Gómez; Eva Ardanaz; Jone Miren Altzibar; Vicente Martin Sanchez; Inés Gómez-Acebo; Javier Llorca; David Muñoz; Adonina Tardón; Rosana Peiró; Rafael Marcos-Gragera; Marina Pollan; Manolis Kogevinas
Journal:  Eur J Epidemiol       Date:  2015-07-24       Impact factor: 8.082

8.  Chronotype Differences in Energy Intake, Cardiometabolic Risk Parameters, Cancer, and Depression: A Systematic Review with Meta-Analysis of Observational Studies.

Authors:  Sofia Lotti; Giuditta Pagliai; Barbara Colombini; Francesco Sofi; Monica Dinu
Journal:  Adv Nutr       Date:  2022-02-01       Impact factor: 11.567

9.  Chronotype and risk of post-menopausal endometrial cancer in the California Teachers Study.

Authors:  Julie Von Behren; Susan Hurley; Debbie Goldberg; Jessica Clague DeHart; Sophia S Wang; Peggy Reynolds
Journal:  Chronobiol Int       Date:  2021-04-27       Impact factor: 3.749

10.  How sedentary and physically active are breast cancer survivors, and which population subgroups have higher or lower levels of these behaviors?

Authors:  Terry Boyle; Jeff K Vallance; Emily K Ransom; Brigid M Lynch
Journal:  Support Care Cancer       Date:  2015-11-12       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.